- WKN: A2JN9W
- ISIN: AT0000A21KS2
- Land: Österreich
Nachricht vom 08.01.2019 | 17:49
IMMOFINANZ intends to issue senior notes in benchmark size
IMMOFINANZ AG / Key word(s): Real Estate/Bond
THE INFORMATION CONTAINED IN THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN, INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, OR INTO OTHER COUNTRIES IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION OF THIS ANNOUNCEMENT MAY BE UNLAWFUL.
IMMOFINANZ intends to issue senior notes in benchmark size
Based on today's approval by the Supervisory Board and subject to favorable market conditions, IMMOFINANZ AG plans to issue fixed rate senior unsecured notes (the "Notes") and mandated several banks to arrange a series of fixed income investor meetings across Europe.
IMMOFINANZ targets an issue amount in benchmark size. The net proceeds of the issue of the Notes will be used for the refinancing of existing debt and general corporate purposes.
The management of IMMOFINANZ expects an investment grade rating in relation to the Notes and IMMOFINANZ, assuming a successful refinancing of outstanding secured debt after the issuance of the Notes in benchmark size.
IMMOFINANZ is a commercial real estate group whose activities are focused on the retail and office segments of seven core markets in Europe: Austria, Germany, Czech Republic, Slovakia, Hungary, Romania and Poland. The core business covers the management and development of properties, whereby the STOP SHOP (retail), VIVO! (retail) and myhive (office) brands represent strong focal points that stand for quality and service. The real estate portfolio has a value of approx. EUR 4.3 billion and covers more than 220 properties. IMMOFINANZ is listed on the stock exchanges in Vienna (leading ATX index) and Warsaw. Further information under: http://www.immofinanz.com
This announcement is mandatory pursuant to Article 17 of the Market Abuse Regulation (MAR).
The information contained in this announcement is for information purposes only and does not purport to be full or complete. No reliance may be placed for any purpose on the information contained in this announcement or its accuracy or completeness. This announcement does not contain or constitute or form part of, and should not be construed as, an offer or invitation to sell, or the solicitation of an offer to buy or subscribe for, any securities.
The distribution of this announcement and the offer and sale of the securities referred to herein may be restricted by law in certain jurisdictions and persons reading this announcement should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.
Any offer of securities to the public that may be deemed to be made pursuant to this communication in any EEA Member State that has implemented EU Directive 2003/71/EC (together with any amendments and applicable implementing measures in any Member State, the "Prospectus Directive") is addressed solely to qualified investors (within the meaning of the Prospectus Directive) in that Member State. This announcement does not constitute a recommendation concerning the private placement of securities described in this announcement (the "Placement"). Investors should consult a professional advisor as to the suitability of the Placement for the person concerned.
This communication is addressed only to and directed only at (i) persons who are outside the United Kingdom or (ii) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order") and (iii) high net worth entities, and other persons to whom it may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons in (i), (ii) and (iii) above together being referred to as "relevant persons"). Any investment activity to which this communication relates will only be available to and will only be engaged with, relevant persons. Any person who is not a relevant person should not act or rely on this document or any of its contents.
This communication is not for public release, publication or distribution, directly or indirectly, in or into the United States (including its territories and possessions, any State of the United States and the District of Columbia). This communication is not and does not constitute or form a part of any offer of, or solicitation to purchase or subscribe for, any securities in the United States. Any such securities have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "Securities Act"). Any such securities may not be offered or sold in the United States or to, or for the account or benefit of, U.S. persons (as such term is defined in Regulation S under the Securities Act), except pursuant to an exemption from the registration requirements of the Securities Act. No public offering of securities will be made in the United States of America.
For additional information contact:
Head of Corporate Communications and Investor Relations
T +43 (0)1 88 090 2290
M +43 (0)699 1685 7290
|Phone:||+43 (0) 1 88090 - 2290|
|Fax:||+43 (0) 1 88090 - 8290|
|Listed:||Regulated Unofficial Market in Berlin, Frankfurt, Munich, Stuttgart; Warschau, Vienna Stock Exchange (Official Market)|
|End of Announcement||DGAP News Service|
Der AKTIONÄR News
19. Januar 10:08 Amazon, Zalando, Adidas und Co: So geht es jetzt weiter
19. Januar 09:12 Morphosys: Neuer Mega-Markt im Fokus
19. Januar 08:52 BASF: Ein starker Wochenabschluss
19. Januar 08:30 Endlich: DAX mit Befreiungsschlag!
News im Fokus
Fresenius Medical Care führt Dialysegerät 4008A für den Einsatz in Schwellenländern ein
18. Januar 2019, 08:02
Fourth Quarter and Full Year 2018 Earnings Call
13. Februar 2019
Original-Research: Netfonds AG (von Montega AG): Kaufen
18. Januar 2019